ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 5 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $1.34M in total
- 5
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 70
- 13F valueReported value at the end of Q2 2026
- $113.0M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PRQR, Q2 2026
No superinvestor reported holding PRQR at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by ProQR Therapeutics N.V. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 (view filing)4:01 PM ET | Jul 31 | 3 days | de Boer Daniel AntonChief Executive Officer | PPurchase | +200.0K | $1.77 | +$354.0K | +66.7%500.0K after | |
| Jul 21, 2026 (view filing)8:00 AM ET | Jul 17 | 4 days | Filius BartDirector | PPurchase | +150.0K | $1.72 | +$257.9K | +100.0%300.0K after | |
| Jul 13, 2026 (view filing)8:00 AM ET | Jul 9 | 4 days | de Boer Daniel AntonChief Executive Officer | PPurchase | +150.0K | $1.74 | +$261.0K | +100.0%300.0K after | |
| Jul 8, 2026 (view filing)2:55 PM ET | Jul 7 | 1 day | de Boer Daniel AntonChief Executive Officer | PPurchase | +150.0K | $1.59 | +$238.5K | New position150.0K after | |
| Jun 30, 2026 (view filing) | Jun 26 | 4 days | Filius BartDirector | PPurchase | +150.0K | $1.54 | +$231.0K | New position150.0K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in ProQR Therapeutics N.V. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 9,015,897 | $16.8M | 0.02% | +2,762,430+44.2% | Added |
| Standard Life Aberdeen plc | 8,932,507 | $16.6M | 0.02% | +5,615,542+169.3% | Added |
| Affinity Asset Advisors, LLC | 5,543,936 | $10.3M | 0.50% | +3,089,658+125.9% | Added |
| Privium Fund Management B.V. | 5,520,024 | $10.3M | 1.89% | +52,875+1.0% | Added |
| Ikarian Capital, LLC | 3,425,930 | $6.37M | 1.04% | +1,933,701+129.6% | Added |
| Woodline Partners LP | 3,277,143 | $6.10M | 0.02% | +3,277,143 | New |
| Heights Capital Management, Inc | 2,762,430 | $5.14M | 1.19% | +2,762,430 | New |
| Morgan Stanley | 1,767,215 | $3.29M | 0.00% | +467,440+36.0% | Added |
| Sphera Funds Management Ltd. | 1,757,458 | $3.27M | 0.47% | +1,757,458 | New |
| Kynam Capital Management, LP | 1,566,317 | $2.91M | 0.16% | 00.0% | Unchanged |